Aptinyx reports positive data from Phase II trial of NYX-783 for PTSD
Biopharma firm Aptinyx has reported positive results from the first Phase II study of its new NMDA receptor modulator, NYX-783,…
Latest News
-
4 hours
-
5 hours
-
23 hours
-
1 day
-
4 hours
-
5 hours
-
23 hours
-
1 day
MediPharm begins trial of cannabis-derived products for kidney disease
Canada-based MediPharm Labs has begun a clinical trial to research and analyse the effectiveness of its cannabis-derived medical products and…
Latest News
View More
WHO’s Solidarity trial shows repurposed drugs for Covid-19 are ineffective
World Health Organization (WHO) has reported that interim data from the Solidarity Therapeutics Trial of remdesivir, hydroxychloroquine, lopinavir / ritonavir and interferon regimens showed the…
Janssen Tremfya shows higher skin clearance rates in plaque psoriasis trial
The Janssen Pharmaceutical Companies of Johnson & Johnson has reported that open-label extension data from Phase III VOYAGE 1 trial of Tremfya (guselkumab) showed high…
Sanofi and Translate Bio find positive preclinical Covid-19 vaccine results
Sanofi’s vaccines global business unit Sanofi Pasteur and Translate Bio have reported preclinical trial results that showed mRNA-based vaccine candidate,…
Evelo Biosciences concludes patient enrolment in atopic dermatitis drug trial
Biotech firm Evelo Biosciences has completed enrolment of 24 patients in the Phase Ib EDP1815-101 trial cohort of investigational oral…
Astex trials of guadecitabine for leukaemia fail to meet primary end point
Astex Pharmaceuticals has reported that Phase III trials of guadecitabine (sSGI-110) failed to meet the primary endpoint of improving overall…
Bayer’s Aliqopa provides prolonged progression-free survival in iNHL trial
Bayer has reported that the Phase III CHRONOS-3 trial of Aliqopa (copanlisib) in combination with rituximab to treat patients with…
Latest Content
View More
Vaxart begins dosing in trial of oral Covid-19 vaccine candidate
Biotechnology firm Vaxart has started dosing participants in a Phase I clinical trial of oral tablet Covid-19 vaccine candidate, VXA-CoV2-1.…
NIH launches clinical trial for Covid-19 therapies
The US National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) has launched the ACTIV-5…
SIMPONI ARIA (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis (pJIA)
SIMPONI ARIA® (golimumab) is a fully human anti-tumour necrosis factor (TNF) alpha monoclonal antibody. It is indicated for the treatment…
SOM Biotech Announces Poster Presentation on the Repurposing of Eravacycline for the Treatment of SARS-CoV-2
SOM Biotech, a biopharmaceutical company specialising in the repositioning of existing drugs for the treatment of diseases with a high…
How the Formedix Visual Define.xml Editor Gives You Faster Define
Define.xml is the metadata that describes the content and formatting of submission datasets and the case report tabulation data. It’s…
In Vivo Pharmacology and PK/PD Testing of Novel Therapeutics Webinar
Noble Life Sciences is pleased to announce that it will be hosting In Vivo Pharmacology and PK/PD Testing of Novel…